- Home
- BLTE vs FSM Comparison
BLTE vs FSM Comparison
Compare BLTE & FSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLTE | FSM |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.3B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLTE | FSM |
|---|---|---|
| Price | $169.05 | $11.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $161.57 | $14.00 |
| AVG Volume (30 Days) | 237.7K | ★ 7.8M |
| Earning Date | 03-16-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 809.52 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $1,256,829,000.00 |
| Revenue This Year | N/A | $0.28 |
| Revenue Next Year | N/A | $11.27 |
| P/E Ratio | ★ N/A | $16.03 |
| Revenue Growth | N/A | ★ 68.17 |
| 52 Week Low | $49.00 | $4.13 |
| 52 Week High | $174.78 | $12.54 |
Technical Indicators
Market Signals| Indicator | BLTE | FSM |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 61.32 |
| Support Level | $156.52 | $11.09 |
| Resistance Level | $171.63 | $12.54 |
| Average True Range (ATR) | 8.88 | 0.56 |
| MACD | 0.26 | 0.08 |
| Stochastic Oscillator | 79.00 | 53.25 |
Price Performance
Historical ComparisonAbout BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
About FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.